BTOG - British Thoracic Oncology Group

On Demand: BTOG Webinar: Mesothelioma Essential Update

BTOG Surgical Webinar: Controversies in the Management of Early Stage Lung Cancer

BTOG Surgical Webinar – Controversies in the Management of Early-Stage Lung Cancer
Thursday 25th March 2021

Biographies
Kelvin Lau
Consultant Thoracic Surgeon, London
I am consultant and lead thoracic surgeon at St Bartholomew’s Hospital, London.
I qualified from the University of Oxford in 2002. During my time at Oxford I was awarded a ICRF scholarship to investigate molecular angiogenesis and vascular targeting of anti-cancer treatment at the Institute of Molecular Medicine for which I was awarded a doctorate of philosophy.
After my training, I obtained his membership in 2005, and was awarded the only cardiothoracic surgery national training number in 2006. I received my training in Glenfield Hospital, Nottingham and London, and went on to complete a minimally invasive thoracic surgery fellowship at the Chinese University of Hong Kong where I was then made honorary assistant professor.

On return to the UK in 2013, I was appointed as the first consultant thoracic surgeon for St Bartholomew’s Hospital where I set up the thoracic surgery service, introduced VATS lobectomy and endobronchial programmes, and recently, one of the first dedicated 24/7 cardiothoracic robotic surgery programme in the UK.

In November 2015, I led the first team in Europe to successfully use the latest version of navigation bronchoscopy and went on to do the first in the world endobronchial microwave ablation of lung tumour in February 2018.

Robert Stevenson
Consultant Clinical Oncologist, Birmingham
Dr Stevenson qualified from the University of Warwick in 2005. He trained within the West Midlands and was appointed as Consultant Clinical Oncologist at University Hospitals Birmingham in 2014. Dr Stevenson is also a visiting consultant to Sandwell and West Birmingham Hospitals NHS Trust and Heart of England NHS trust. Dr Stevenson specialises in the treatment of lung and urological cancers with chemotherapy, hormonal therapy and radiotherapy.

Dr Stevenson is also involved in 4-dimensional and stereotactic lung radiotherapy within Birmingham and has experience in delivering Cyberknife treatment to an early stage of lung cancer.

Dr Stevenson has published papers in peer-reviewed journals and is the principal investigator (PI) for a number of national clinical trials.

Malcolm Will
Consultant Thoracic Surgeon, The Royal Infirmary of Edinburgh. Specialist interest in minimally invasive thoracic surgery, airway diseases, chest wall disorders and interventions for COPD

 

BTOG Webinar: WCLC20 in an Hour

BTOG Steering Committee members present an update on relevant data/research presented at WCLC 2020 (postponed from September 2020 to January 2021).

Welcome Tom Newsom-Davis
Top Medical Oncology Abstracts Riyaz Shah
Q&A Tom Newsom-Davis
Top Clinical Oncology Abstracts Fiona McDonald
Q&A Tom Newsom-Davis
Top Respiratory Medicine Abstracts Richard Booton
Q&A & Close Tom Newsom-Davis

 

Chair: Dr Tom Newsom-Davis – BTOG Steering Committee Vice-Chair
Faculty: Dr Riyaz Shah, Consultant Medical Oncologist, Kent Oncology Centre; Dr Fiona McDonald, Consultant Clinical Oncologist, Royal Marsden Hospital; Professor Richard Booton, Clinical Director for Lung Cancer & Thoracic Surgery and Professor of Respiratory Medicine at Manchester University NHS Foundation Trust and University of Manchester.

On Demand: Molecular Sub-types Beyond EGFR, ALK, ROS BTOG Masterclass

Aims: to educate delegates on benefits of next generation sequencing (NGS) genotyping to identify
rare variants for NHS-reimbursed therapies, compassionate use programmes and trials enrolment.
All data will pertain to advanced NSCLC.

Chair: Professor Sanjay Popat
17:30 Introduction Sanjay Popat
17:31 BRAF, KRAS, & insertion mutations you need to know about Raffaele Califano
17:46 Splices and fusions you need to know about Alastair Greystoke
18:01 How will we find suitable patients? Rachel Butler
18:16 Q&A

18:30 Close

 

BTOG Masterclass: Stage III NSCLC

BTOG Masterclass on Stage III NSCLC

Approved by the Federation of the Royal Colleges of Physicians of the United Kingdom 

BTOG Masterclass: Diagnosing Lung Cancer

BTOG Masterclass: Diagnosing Lung Cancer

 

Lung Cancer in the time of COVID - BTOG Webinar

 

Chair: Professor Sanjay Popat

Panel: Professor David Baldwin (Respiratory Medicine); Mr John Edwards (Surgery); Professor Samreen Ahmed (Medical Oncology); Professor Matthew Hatton (Clinical Oncology); Josie Roberts (Nursing); Dr Rhiannon Walters-Davies (Pharmacy)

Each panellist briefly summarises how practice has changed in their specialty and focus on moving forward with endemic COVID

Panel discussion & questions from webinar attendees.

 

 

 

On Demand: ESMO 2020 in an Hour - BTOG Webinar

 

Chair: Dr Tom Newsom-Davis – BTOG Steering Committee Vice-Chair

Faculty:

Dr Shobhit Baijal, Consultant Medical Oncologist, University Hospital Birmingham NHST

Dr David Gilligan, Consultant Oncologist and Associate Lecturer, University of Cambridge – Cambridge University Hospitals NHST

Professor James Spicer, Professor of Experimental Cancer Medicine and Consultant in Medical Oncology, King’s College London – Guy’s and St Thomas’ NHSFT

 

BTOG Steering Committee members will present an update on relevant data/research presented at ESMO 2020 on the topics below.

• Stage III NSCLC
• Small Cell Lung Cancer
• TKIs and Other Targeted Therapies

With Q&A after each presenter and at the end of whole session.

On-demand: WCLC 2020 Virtual Presidential Symposium Abstracts in an Hour - BTOG Webinar

 

Exploring studies and advances in thoracic oncology showcased at the IASLC WCLC 2020 Virtual Presidential Symposium on 8th August and the potential implications on UK practice.

View on demand at btogwebinars.org

 

Programme

Chair: Professor Sanjay Popat

The faculty will disseminate the trial data presented, discuss in UK context, and take questions.

ORIENT-11

Alastair Greystoke

Abstract 1: ORIENT-11: Sintilimab + Pemetrexed + Platinum as First-Line Therapy for Locally Advanced or Metastatic Non-Squamous NSCLC

(Speaker: Zhang Li, China)

eXalt3

Fiona Blackhall

Abstract 2: Phase 3 Randomized Study of Ensartinib vs Crizotinib in Anaplastic Lymphoma Kinase (ALK)–Positive NSCLC Patients: eXalt3

(Speaker: Leora Horn, USA)

CheckMate-743

Riyaz Shah

Abstract 3: First-Line Nivolumab + Ipilimumab vs Chemotherapy in Unresectable Malignant Pleural Mesothelioma: CheckMate 743

(Speaker: Paul Baas, Netherlands)

 

Faculty

Professor Sanjay Popat is Consultant Thoracic Medical Oncologist at the Royal Marsden Hospital and Professor of Thoracic Oncology at the Institute of Cancer Research and Chair of the BTOG Steering Committee

Dr Alastair Greystoke is Clinical Senior Lecturer and Honorary Consultant at the Newcastle University and the Northern Centre for Cancer Care

Professor Fiona Blackhall is Professor of Thoracic Oncology and Honorary Consultant in Medical Oncology at the Christie NHS Foundation Trust

Dr Riyaz Shah is a Consultant Medical Oncologist at Kent Oncology Centre, Maidstone and Tunbridge Wells NHS Trust

BTOG Webinar: ASCO in an hour

 

In collaboration with Roy Castle Lung Cancer Foundation (RCLCF)

Approved for 1 CPD credit by the Federation of the Royal Colleges of Physicians of the United Kingdom (Ref: 131661) until July 2nd 2020.

#BTOGASCO20

BTOG and RCLCF usually hold an annual in-person meeting to highlight the latest thoracic oncology treatment and research showcased at the annual ASCO meeting.  For ASCO 2020, which is going ahead virtually, we are going to present a one hour webinar

Join BTOG Steering Committee members for an update on relevant data/research presented at ASCO 2020 on:

• advanced stage NSCLC: immunotherapy
• advanced stage NSCLC: targeted therapies
• locally advanced NSCLC
• SCLC and
• mesothelioma